TruBridge (NASDAQ:TBRG), a leading provider of healthcare technology solutions for rural and community hospitals, announced today that it has postponed its fourth quarter and year-end 2025 earnings release and conference call, previously scheduled for Monday, March 16, 2026, to allow additional time for the completion of its year-end audit procedures. TruBridge will issue a subsequent press release confirming the date of the release of fourth quarter and year-end 2025 financial results and the date and time of the rescheduled earnings call (and instructions to access the call) as soon as possible.

While conducting final procedures in connection with the preparation of TruBridge's financial statements for the fiscal year ended December 31, 2025, errors were identified in the consolidated financial statements for the year ended December 31, 2024 as well as out-of-period errors in the condensed financial statements for the quarters ended March 31, June 30, and September 30, 2025. The majority of these errors relate to accounting for revenue, software development costs, and share-based payments. As a result, TruBridge is required to make revisions to its previously issued consolidated financial statements for the year ended December 31, 2024, filed with TruBridge's Annual Report on Form 10-K for the year then ended. TruBridge believes that such errors did not result in a material misstatement of its previously issued financial statements, and the errors are non-cash in nature and do not impact TruBridge's operations or liquidity. The errors were identified as management continues to work to improve TruBridge's financial reporting processes. TruBridge requires additional time and effort to complete the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "2025 Form 10-K"). TruBridge expects to file the 2025 Form 10-K within the 15-day extension period granted by the Securities and Exchange Commission, as well as issue its fourth quarter and year-end 2025 financial results and hold its rescheduled earnings call by March 31, 2026.

The errors described above relate to certain deficiencies in TruBridge's internal control over financial reporting that management determined to be material weaknesses as of December 31, 2025. These material weaknesses related to (i) revenue recognition under ASC 606, including controls to identify and evaluate contract modifications, validate manual interventions, ensure completeness and accuracy of information used in billing and revenue recognition, timely record credits, rebills and similar revenue‑related adjustments, and evaluate terms affecting recognition over-time versus point-in-time; (ii) stock‑based compensation under ASC 718, including controls to identify and document award modifications (including severance‑related outcomes), application of appropriate valuation bases, and timely true‑ups for changes in performance conditions; and (iii) capitalized software development costs recognized under ASC 985-20, including controls to determine and document technological feasibility, cease capitalization when products are available for general release, support the population and allocation of capitalizable costs with complete and accurate project data, and expense maintenance and support activities as incurred.